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Abstract 
Background: Diabetes mellitus is one of the most important risk factors for atherosclerosis. However, the mecha‑
nisms underlying high‑glucose‑induced atherosclerosis remain unclear. This study was designed to observe the 
effects of high‑glucose stimulation on the permeability of cultured human umbilical vein endothelial cells (HUVECs), 
and to explore the effects of RhoA–Rho‑associated protein kinase (ROCK) signal transduction pathway activation and 
myosin light chain (MLC) phosphorylation.
Methods: HUVECs were cultured in conventional M199 medium to produce endothelial cell monolayers, and stimu‑
lated with high‑glucose‑M199 medium. The transmembrane transport of dextran and THP‑1 cells and levels of MLC 
phosphorylation were measured. The effects of blocking the RhoA‑ROCK pathway using dnRhoA or the ROCK inhibi‑
tor Y27632 on dextran and THP‑1 transport and MLC phosphorylation were observed.
Results: Transendothelial migration of dextran and THP‑1 cells were significantly increased by stimulation of HUVEC 
monolayers with high glucose (P < 0.05). This effect was attenuated by treatment with dnRhoA or Y27632.
Conclusion: High‑glucose stimulation upregulated MLC phosphorylation and increased endothelial permeability by 
activating the RhoA‑ROCK signaling pathway in HUVECs in vitro.
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Background
Diabetes mellitus is one of the most important risk factors 
for atherosclerosis. However, the mechanisms underly-
ing high-glucose-induced atherosclerosis remain unclear. 
Previous studies have demonstrated that high glucose can 
destroy endothelial function [1–3], which is an initiating 
condition for atherosclerosis. Rho family GTPases, espe-
cially RhoA, play an important role in maintaining and 
adjusting endothelial barrier function [4, 5]. Activation of 
RhoA enhances the activity of its downstream Rho kinase 
[Rho-associated protein kinase (ROCK)], which in turn 
induces myosin light chain (MLC) phosphorylation [6]. 
MLC phosphorylation results in the formation of gaps 
between adjacent cells through cytoskeleton contraction, 
resulting in increased membrane permeability. Figure  1 
shows the presumed high-glucose-induced cellular path-
way linking to the Rho-dependent steps.
In this study, we cultured human umbilical vein 
endothelial cells (HUVECs) in  vitro, and observed the 
effects of high-glucose stimulation on endothelial mon-
olayer permeability. We also examined the effects of 
blocking the RhoA-ROCK signaling pathway using domi-
nant negative RhoA (dnRhoA) and the specific ROCK 
inhibitor Y27632 on the high-glucose-induced increase 
in endothelial permeability.
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Methods
Cells and reagents
HUVECs (ATCC, USA) were incubated in M199 (Gibco, 
USA) medium supplemented with low-serum growth 
supplement (Gibco, USA), 10-mg/l gentamicin, and 
0.25-mg/l amphotericin in a 5 % CO2 incubator at 37 °C 
and 95 % humidity. Sixth-passage HUVECs were seeded 
in 100-mm diameter Petri dishes prior to further treat-
ments. When the cells reached confluence, they were 
incubated with M199 without low-serum growth supple-
ment for 10 h. Cells in the stationary phase were used for 
experiments. THP-1 cells (ATCC, USA) were incubated 
with RPMI-1640 medium containing 50  μmol/l 2-mer-
captoethanol, 10 % fetal bovine serum, 100 IU/ml penicil-
lin, and 100 μg/ml streptomycin in a 5 % CO2 incubator 
at 37  °C and 95  % humidity. The glucose concentration 
of the ordinary M199 medium was 5.6  mmol/l. High-
glucose medium was prepared by adding d-glucose to 
M199 to reach a final concentration of 25  mmol/l. Cell 
lysates were prepared using 25  mmol/l HEPES, pH 
7.5, 150  mmol/l NaCl, 1  % NP-40, 10  mmol/l MgCl2, 
1  mmol/l ethylenediamine tetraacetic acid, 2  % glyc-
erol, 10 μg/ml leupeptin, 10 μg/ml aprotinin, 1 mM NaF, 
and 1  mM sodium vanadate. Dominant negative RhoA 
cDNAs (DN: N19) were purchased from UMR Resource 
Center (USA) and Y27632 were purchased from Selleck 
Chemicals (USA).
Experimental groups
Cells were divided into six groups: control group, high-
glucose group, dnRhoA group, Y27632 group, high-
glucose  +  dnRhoA group, and high-glucose  +  Y27632 
group. Control HUVECs were incubated with ordinary 
M199 medium (glucose concentration 5.6  mmol/l). 
HUVECs in the high-glucose groups were incubated 
with high-glucose medium. HUVECs in the dnRhoA 
groups were incubated with medium containing dnRhoA 
10  μl/10  ml and HUVECs in the Y27632 groups were 




HUVECs were grown in a Transwell system using 0.4-μm 
micropore polycarbonate membranes (Millipore, USA) 
until complete confluence, resulting in the formation of 
an endothelial cell monolayer barrier. Fluorescein isothi-
ocyanate-labeled dextran (MW 70,000; Seebio, Shanghai, 
China) 100 mg/l was added to the bottom well, and the 
relevant medium was added to the bottom and top wells, 
according to the different groups. After 2 h of incubation, 
100 μl of medium was removed from the bottom and top 
wells and the fluorescence was determined using a fluo-
rescence spectrometer. The rate of transendothelial dex-
tran transfer was calculated as %dextran/h/cm2.
Transmembrane migration of THP‑1 cells
The back of Transwell with 8.0-μm micropores (Mil-
lipore, USA) were coated with 50  % Matrigel. HUVECs 
were seeded on the other side of the Transwell mem-
brane until complete confluence and formation of an 
endothelial monolayer barrier. THP-1 cells in the station-
ary phase were labeled with 2′,7′-bis-(2-carboxyethyl)-
5-(and-6)-carboxyfluorescein acetoxymethyl ester 
(Fanbo, Beijing, China) (1 × 105 cells/well) and seeded on 
the surface of the HUVECs, which were incubated with 
medium according to the different groups for 6 h. After 
treatment, nonmigrated cells were removed from the 
upper side of the membrane with cotton swabs, and the 
cells on the lower surface of the membrane were fixed, 
stained and observed under an inverted microscope.
MLC phosphorylation
HUVECs were divided into the above six groups and 
incubated for 6  h. Proteins were extracted from cell 
lysates and protein concentrations were determined 
using bovine serum albumin assay. MLC protein and 
phosphorylation levels were measured by western 
Fig. 1 Presumed high glucose‑induced cellular pathway linking to 
the Rho‑dependent steps
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blotting using phosphorylated MLC antibody (1:500; 
Cell Signaling) as the primary antibody (Thr18/Ser19) 
and horseradish peroxidase-labeled goat anti-rabbit 
antibody (1:3000; Santa Cruz) as the secondary antibody. 
After visualization, proteins were eluted from the polyvi-
nylidene fluoride membrane, followed by MLC antibody 
hybridization and visualization. Total protein levels of 
MLC were determined. The intensities of the gray bands 
were read using Image J software. The ratio of p-MLC 
to MLC in each group was calculated. Glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) was used as an 
internal reference.
Statistical analysis
All data were analyzed using SPSS 13.0 software. Mean 
values were compared among multiple groups using one-
way analysis of variance and least significant difference 
t-tests. A value of P  <  0.05 was considered statistically 
significant.
Results
Transendothelial transfer of dextran and THP‑1 cells
Transendothelial transport of dextran and THP-1 cells 
were significantly increased (P  <  0.01) by high-glucose 
stimulation. The administration of dnRhoA or the ROCK 
inhibitor Y27632 significantly attenuated the effects of 
high-glucose medium (Table 1).
MLC phosphorylation
There was no significant difference in MLC protein 
expression among the groups and MLC phospho-
rylation was not detectable in HUVECs cultured at 
normal glucose concentration. However, MLC phos-
phorylation was significantly increased by stimulation 
with high glucose. Administration of dnRhoA or the 
ROCK inhibitor Y27632 significantly suppressed the 
high-glucose-induced MLC phosphorylation (Fig.  2; 
Table 1).
Discussion
Atherosclerosis is a complex chronic inflammatory pro-
cess associated with excessive inflammation and lipid 
accumulation [7]. Its major initiating factor is local 
endothelial cell injury. Endothelial cell injury can result 
in increased endothelial permeability and transendothe-
lial transport of lipids and cellular blood components to 
the intima [8]. Initial fatty streaks form after a series of 
processes such as inflammatory reaction, oxidative stress, 
and smooth muscle cell migration and proliferation. 
These fatty streaks subsequently develop into plaques, 
including unstable plaques, which may then rupture and 
cause clinical events. The process is thus strongly asso-
ciated with inflammation and endothelial dysfunction. 
Diabetes mellitus is a major risk factor for atherosclero-
sis. Although the mechanisms underlying high-glucose-
induced atherosclerosis remain unclear, previous studies 
have confirmed that high glucose can destroy endothelial 
function, which is the initiating factor for atherosclerosis.
In this study, we cultured HUVECs in  vitro to create 
single membranous structures. Transmembrane trans-
port of dextran and THP-1 cells were increased by high-
glucose stimulation, confirming the destructive effects of 
high glucose on endothelial function at the cellular level. 
These findings may explain why diabetic patients are at 
high risk of developing atherosclerosis.
The integrity of vascular endothelial function depends 
mainly on the normal functioning of cytoskeletal pro-
teins and intercellular connections. A variety of physi-
cal factors (such as hemodynamic changes) and 
chemical factors (such as inflammatory cytokines) can 
affect expression levels of cytoskeletal proteins and inter-
cellular junction proteins through specific signal trans-
duction pathways, leading to endothelial dysfunction and 
increased permeability. Protein phosphorylation repre-
sents an important mechanism for regulating cytoskel-
etal protein function [9–11]. MLC phosphorylation 
can induce cytoskeleton contraction, thus opening gaps 
Table 1 Quantitative analyses of transendothelial transfer of dextran and THP-1 cells and MLC phosphorylation
* P < 0.01 vs. control group; # P < 0.01 vs. high-glucose group
Group n Transendothelial transfer rate of dextran 
(%dextran/h/cm2)
THP‑1 transendothelial migration (cell/
HP)
MLC phosphorylation
Control 5 9.09 ± 0.49 7.00 ± 1.22 0.00 ± 0.00
High glucose 5 16.72 ± 1.51* 30.00 ± 6.44* 0.73 ± 0.28*
dnRhoA 5 10.31 ± 1.97 10.00 ± 1.87 0.16 ± 0.02
Y27632 5 9.98 ± 0.78 9.00 ± 1.58 0.23 ± 0.03
High‑glucose + dnRhoA 5 13.04 ± 0.91# 17.00 ± 1.87*,# 0.34 ± 0.04#
High glucose + Y27632 5 10.96 ± 0.39# 18.20 ± 1.79*,# 0.46 ± 0.03#
F 29.503 39.210 24.205
P 0.000 0.000 0.000
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between cells and causing increased permeability [12–
14]. In the present study, although MLC protein expres-
sion levels in HUVECs were unaffected by high-glucose 
stimulation, MLC phosphorylation levels were increased, 
indicating a role for MLC phosphorylation in high-glu-
cose-induced endothelial permeability.
Previous studies confirmed that the Rho fam-
ily GTPases, especially RhoA, played a crucial role in 
maintaining and regulating endothelial barrier func-
tion [4, 5]. RhoA activation enhanced activity of down-
stream ROCK, the key function of which is to induce 
MLC phosphorylation [6]. MLC phosphorylation in turn 
could increase endothelial permeability via cytoskel-
eton contraction and subsequent loss of endothelial cell 
adhesion and connections [3]. The results of the current 
study demonstrated that MLC phosphorylation levels 
and endothelial permeability were indeed increased by 
culture of HUVECs in high-glucose medium. However, 
this high-glucose-induced permeability was partially 
inhibited and MLC phosphorylation levels noticeably 
diminished by suppression of the RhoA-ROCK signal-
ing pathway with dnRhoA or Y27632. These findings 
suggest that high-glucose stimulation upregulated MLC 
phosphorylation and destroyed endothelial function 
by activating the RhoA-ROCK system. The mechanism 
responsible for the high-glucose-induced increase in 
endothelial permeability may thus be as follows: high glu-
cose  →  RhoA activation  →  ROCK activation  →  MLC 
phosphorylation  →  cytoskeleton contraction  →  gap 
between cells → permeability increase.
In addition to ROCK, MLC kinase is also an upstream 
regulatory kinase of MLC phosphorylation. We there-
fore used a control group to account for the possible 
effects of Y27632 and dnRhoA solvent on MLC kinase 
Fig. 2 Effects of dnRhoA and Y27632 on high‑glucose‑induced MLC phosphorylation. MLC phosphorylation was not detectable in HUVECs cul‑
tured at normal glucose concentration but was significantly increased after stimulation with high glucose. MLC phosphorylation was significantly 
reduced by blocking RhoA and ROCK activities with dnRhoA and Y27632, respectively. Glyceraldehyde 3‑phosphate dehydrogenase (GAPDH) was 
used as an internal reference. a Western blot assay; b bar graph. *P < 0.01 vs. control group; #P < 0.01 vs. high‑glucose group
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activation, which could affect MLC phosphorylation lev-
els. The results showed that Y27632 and dnRhoA alone 
could induce a small amount of MLC phosphoryla-
tion, but the mechanisms responsible for this phenom-
enon are unclear. Further investigations are needed to 
determine if Y27632, dnRhoA, or their solvent compo-
nents affect MLC kinase activity or intracellular calcium 
concentrations.
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